Next Generation Sequencing (NGS) in Agrigenomics Market Report 2025

The next-generation sequencing (NGS) in the agrigenomics market size has grown rapidly in recent years. It will grow from $2.25 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. Growth during the historic period was driven by increasing demand for high-yield, disease-resistant crop varieties, the growing need for sustainable agricultural practices to combat climate change, greater adoption of precision farming and genomics-assisted breeding techniques, rising investment in agricultural biotechnology research and development, and heightened awareness of food security and the importance of genetic diversity.

The next-generation sequencing (NGS) in the agrigenomics market size is expected to see rapid growth in the next few years. It will grow to $4.0 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. Growth in the forecast period is expected to be supported by increased government funding and favorable policies for agrigenomics initiatives, wider availability of advanced sequencing technologies, greater integration of big data and bioinformatics in crop and livestock improvement, expanding collaborations among agribiotech companies, research institutions, and farmers, and a stronger focus on improving livestock health and productivity through genetic analysis. Key trends anticipated during this period include advancements in high-throughput sequencing technologies, integration of bioinformatics and big data analytics, technological improvements that reduce cost and complexity, developments in long-read sequencing methods, and innovations in gene-editing tools.

The growing concerns about food security are anticipated to drive the growth of next-generation sequencing (NGS) in the agrigenomics market in the coming years. Food security refers to ensuring that all individuals have consistent access to sufficient, safe, and nutritious food to meet their dietary needs for an active and healthy life. Rising concerns about food security are largely due to factors such as population growth, which increases food demand beyond the current agricultural production capacity. NGS in agrigenomics addresses these challenges by enabling the development of improved crop varieties with higher yields, enhanced disease resistance, and better climate adaptability. For example, in August 2025, the United States Department of Agriculture, a US-based government agency, reported that food insecurity affected 13.5% (18 million) of American families in 2023, up from 12.8% (17 million) in 2022. Therefore, the increasing concerns regarding food security are fueling the expansion of NGS in the agrigenomics market.

Companies in the NGS agrigenomics market are focusing on creating advanced solutions, such as single-reaction sequencing, to provide cost-effective and accurate genomic insights that accelerate crop and livestock improvement for sustainable agriculture. Single-reaction sequencing is a technique that consolidates multiple sequencing processes into one molecular assay, allowing simultaneous genome-wide sequencing and targeted genotyping efficiently. For instance, in May 2022, Gencove Inc., a US-based biotechnology company, introduced InfiniSEEK in collaboration with NEOGEN Corporation, a US-based firm specializing in food and animal safety products. This solution integrates low-pass whole genome sequencing with high-coverage genotyping in a single assay, delivering cost-effective and precise genomic insights. It enables comprehensive sequencing of cattle populations to prevent selection bias, uncover new genetic traits, and manage over 400 bovine traits with clinical-grade accuracy validated to be over 99% concordant with deep sequencing.

In April 2022, LGC Ltd., a UK-based life sciences measurement and testing company, acquired Rapid Genomics for an undisclosed sum. This acquisition aims to enhance LGC’s position in the agrigenomics market by expanding its high-throughput NGS services and integrating Rapid Genomics’ advanced genotyping technologies, thereby offering more comprehensive and cost-effective solutions for plant, livestock, and aquaculture genetics. Rapid Genomics LLC is a US-based company that provides a wide range of NGS products and services for agrigenomics.

Major players in the next generation sequencing (ngs) in agrigenomics market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Daicel Corporation, Takara Holdings Inc., Tecan Group Ltd., Azenta Life Sciences, 10x Genomics Inc., Novogene Corporation, Twist Bioscience Inc., Oxford Nanopore Technologies Ltd., Genotypic Technology Pvt. Ltd., CD Genomics Inc., Zymo Research Corp., Genome Life Sciences Pvt. Ltd., Arraygen Technologies Pvt. Ltd., SciGenom Labs Pvt. Ltd., BGI Group, and Paragon Genomics Inc.

North America was the largest region in the next generation sequencing (NGS) in agrigenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next generation sequencing (NGS) in agrigenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the next generation sequencing (NGS) in agrigenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Next-generation sequencing (NGS) in agrigenomics refers to advanced DNA sequencing technologies used to study the genetic composition of plants and agricultural organisms. It enables rapid and accurate genome decoding, aiding in the improvement of crop traits such as yield, disease resistance, and stress tolerance. This technology promotes sustainable agriculture by accelerating breeding programs and enhancing crop improvement strategies.

The primary types of next-generation sequencing (NGS) in agrigenomics include nanopore, NextSeq, NovaSeq, and Sequel. A nanopore is an extremely small hole, measured in billionths of a meter, through which individual molecules such as DNA or proteins pass for analysis. The different sample types include blood samples, plant tissue samples, soil samples, microbial cultures, and seed samples. The major workflow stages involve sample preparation, sequencing, data analysis, data interpretation, bioinformatics, and data management. The key applications include plant genomics, animal genomics, microbial genomics, food safety testing, and biodiversity conservation. These solutions are utilized by various end users, such as agricultural biotechnology companies, research institutions, food and beverage companies, government and regulatory bodies, and farmers.

The next generation sequencing (NGS) in agrigenomics market research report is one of a series of new reports that provides next generation sequencing (NGS) in agrigenomics market statistics, including the next generation sequencing (NGS) in agrigenomics industry global market size, regional shares, competitors with the next generation sequencing (NGS) in agrigenomics market share, detailed next generation sequencing (NGS) in agrigenomics market segments, market trends, and opportunities, and any further data you may need to thrive in the next generation sequencing (NGS) in agrigenomics industry. This next generation sequencing (NGS) in agrigenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The next generation sequencing (NGS) in agrigenomics market consists of revenues earned by entities by providing services such as whole genome sequencing services, targeted resequencing services, transcriptome sequencing services, genotyping services, and epigenetic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation sequencing (NGS) in agrigenomics market also includes sales of sequencing instruments, sequencing reagents, consumables, and library preparation kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.